These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9549031)

  • 1. Reproductive hormones and gastrointestinal motor disorders: a new dimension in therapeutics.
    Cohen S; Parkman HP
    Dig Dis; 1998; 16(1):1-2. PubMed ID: 9549031
    [No Abstract]   [Full Text] [Related]  

  • 2. Relationship of reproductive hormones and neuromuscular disease of the gastrointestinal tract.
    Mathias JR; Clench MH
    Dig Dis; 1998; 16(1):3-13. PubMed ID: 9549032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuromuscular diseases of the gastrointestinal tract. Specific disorders that often get a nonspecific diagnosis.
    Mathias JR; Clench MH
    Postgrad Med; 1995 Mar; 97(3):95-8, 101-2, 105-8. PubMed ID: 7877932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pointers for dealing with neuromuscular GI disorders.
    Goodman MW
    Geriatrics; 1982 Oct; 37(10):117-9, 122-4. PubMed ID: 7117839
    [No Abstract]   [Full Text] [Related]  

  • 5. Neuromuscular disorders of the gastrointestinal tract.
    Cohen S
    Hosp Pract (Off Ed); 1983 Apr; 18(4):121-4, 130-1. PubMed ID: 6404771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of endometriosis and neuromuscular disease of the gastrointestinal tract: new insights.
    Mathias JR; Franklin R; Quast DC; Fraga N; Loftin CA; Yates L; Harrison V
    Fertil Steril; 1998 Jul; 70(1):81-8. PubMed ID: 9660426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Gastrointestinal endometriosis].
    Osuga Y
    Nihon Rinsho; 2001 Jan; 59 Suppl 1():196-200. PubMed ID: 11235164
    [No Abstract]   [Full Text] [Related]  

  • 8. [Diseases of gastrointestinal motility. Treatment with motility-modifying substances].
    Storr M; Allescher HD
    Med Monatsschr Pharm; 2003 Aug; 26(8):260-9. PubMed ID: 12953379
    [No Abstract]   [Full Text] [Related]  

  • 9. Neuromuscular disease of the gastrointestinal tract.
    Chokhavatia S; Anuras S
    Am J Med Sci; 1991 Mar; 301(3):201-14. PubMed ID: 2000894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and treatment of enteric neuromuscular diseases.
    Camilleri M
    Clin Auton Res; 2003 Feb; 13(1):10-5. PubMed ID: 12664242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential of ghrelin as a therapeutic approach for gastrointestinal motility disorders.
    Peeters TL
    Curr Opin Pharmacol; 2006 Dec; 6(6):553-8. PubMed ID: 17011824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New vistas on gastrointestinal motility: from physiology to therapy an international symposium in Rome.
    Currò D; Holzer P
    Eur Rev Med Pharmacol Sci; 2008 Aug; 12 Suppl 1():1-2. PubMed ID: 18924439
    [No Abstract]   [Full Text] [Related]  

  • 13. Neuromuscular diseases and disorders of the alimentary system.
    Chaudhry V; Umapathi T; Ravich WJ
    Muscle Nerve; 2002 Jun; 25(6):768-84. PubMed ID: 12115965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ion channels as targets for treatment of gastrointestinal motility disorders.
    Farrugia G
    Eur Rev Med Pharmacol Sci; 2008 Aug; 12 Suppl 1():135. PubMed ID: 18924455
    [No Abstract]   [Full Text] [Related]  

  • 15. Gastrointestinal motility and perception disorders re-visited.
    Malagelada JR
    Rev Esp Enferm Dig; 2004 Jul; 96(7):477-80, 481-4. PubMed ID: 15283630
    [No Abstract]   [Full Text] [Related]  

  • 16. Stem cell therapy for GI neuromuscular disorders.
    Bitar KN; Raghavan S
    Curr Gastroenterol Rep; 2014 Dec; 16(12):419. PubMed ID: 25381632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early investigational therapeutics for gastrointestinal motility disorders: from animal studies to Phase II trials.
    Valentin N; Acosta A; Camilleri M
    Expert Opin Investig Drugs; 2015 Jun; 24(6):769-79. PubMed ID: 25971881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormones of the gut-brain axis as targets for the treatment of upper gastrointestinal disorders.
    Sanger GJ; Lee K
    Nat Rev Drug Discov; 2008 Mar; 7(3):241-54. PubMed ID: 18309313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe gastrointestinal dysmotility developed after treatment with gonadotropin-releasing hormone analogs.
    Cordeddu L; Bergvall M; Sand E; Roth B; Papadaki E; Li L; D'Amato M; Ohlsson B
    Scand J Gastroenterol; 2015 Mar; 50(3):291-9. PubMed ID: 25592315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacotherapy of altered brain-gut interactions in functional gastrointestinal disorders.
    Clouse RE
    J Pediatr Gastroenterol Nutr; 1997; 25 Suppl 1():S18-9. PubMed ID: 9285856
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.